NormOxys
NormOxys, Inc | Harnessing the Advantages of a New Class of Small Molecule Drug Derivatives of Polyol Phosphates for Oncology Treatment.
Employees
Enterprise value
$70—105m
loading funding rounds…
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.